Anthem Biosciences files draft papers with SEBI for ₹3,395 crore IPO

The proposed initial public offer (IPO) is entirely an offer for sale (OFS) worth ₹3,395 crore by promoters, investors and other selling shareholders, according to a Draft Red Herring Prospectus (DRHP).

Leave a Reply

Your email address will not be published. Required fields are marked *